What the studies show
Inhibiting NNMT with 5-amino-1MQ reduced fat mass and improved metabolic measures in mouse models of diet-induced obesity. No human trial has tested it for weight or metabolism.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
In context
5-Amino-1MQ is a small molecule — not a peptide — that blocks an enzyme called NNMT, which is elevated in the fat tissue of obese people. In mice, inhibiting NNMT reduces fat mass and improves metabolic markers, which is the basis of its sale as a weight-loss and metabolic 'peptide'. It has never been tested in a controlled human trial and is not approved anywhere.
5-Amino-1MQ is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is 5-Amino-1MQ proven to help with fat loss / metabolic health?
What studies are behind the grade?
Is 5-Amino-1MQ approved for this?
Other outcomes for 5-Amino-1MQ
- DSafety in humansadverseNone
Written and maintained by LYO Research — how pages are written and checked. Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →